FDA Approves New Treatment for Sickle Cell Disease

GROUND BREAKING NEWS!!! The FDA has approved a second drug for patients living with sickle cell disease.  With the recent approval of Endari, patients now have an additional option to help reduce the complications associated with the disease.  Read more here

 

 

Share this post

Share on facebook
Share on twitter
Share on linkedin
Share on email
CONTACT US
KEEP IN TOUCH
Sign up for our email list, or follow us on social media, to stay in-the-know about the Maryland Sickle Cell Disease Association
Scroll to Top